Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results
2007 | 79 | 2 | 134-141

Article title

Patients With Abdominal Sepsis - Options for Using Adjuvant Intravenous Immunoglobulins



Title variants

Languages of publication












Physical description


1 - 2 - 2007
24 - 9 - 2007


  • Department of Surgery, Klinikum Konstanz, Academic Teaching Hospital University, Freiburg


  • Rangel-Frausto MS, Pittet D, Costigan, RN et al.: The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 1995; 273: 117-23.
  • Le Gall JR, Lemeshow S, Saulnier F: A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study. JAMA 1993; 270: 2957-63.
  • Reist K, Hilfiker O, Stepniewski MS et al.: Sepsis-Score in der operativen Intensivmedizin. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1996; 31.
  • Bein T, Unertl K: Möglichkeiten und Grenzen von Score-Systemen in der Intensivmedizin. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1993; 28: 476-83.
  • Heney D, Lewis IJ, Evans SW et al.: Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis 1992; 165: 886.
  • Heuer HO, Darius H, Lohmann HF et al.: Platelet-activating factor type activity in plasma from patients with septicemia and other diseases. Lipids 1991; 26: 1381.
  • Rosman C, Grond J, Buurman WA et al.: Fish oil increases the release of tumour necrosis factor and interleukin-6 and has no effect on the incidence of multiple organ failure in rats with peritonitis. Eur J Surg 1993; 159: 563.
  • Döcke WD, Randow F, Syrbe U et al.: Monocyte deactivation in septic patients: restoration by IFNg treatment. Nature Medicine 1997; 3: 678-81.
  • Assicot M, Gendrel D, Carsin H et al.: High serum procalcitonin concentration in patients with sepsis and infection. Lancet 1993; 341: 515.
  • Becker KL, Nash DR, Silva OL et al.: Increased serum and urinary calcitonin levels in patients with pulmonary disease. Chest 1981; 79: 211.
  • Bone RC: The pathogenesis of sepsis. Ann Intern Med 1991; 115: 457.
  • Goris RJA, Boekhorst TPA, Nuytinck JKS: Multiple organ failure. Arch Surg 1985; 118: 1109.
  • Reith HB, Mittelkötter U, Wagner R et al.: Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med 2000; 26: S165-69.
  • Beier W: Procalcitonin (ProCt) - ein innovativer Inflammationsparameter mit prognostischen Eigenschaften. Anästh Intensivmed 36: XVIII, 1994 (editorial).
  • Huttemeier PC, Ritter EF, Benveniste H: Calcitonin gene-related peptide mediates hypotension and tachycardia in endotoxin rats. Am J Physiol 1993; 265: 4767.
  • Joyce CD, Fiscus RR, Wang X et al.: Calcitonin related peptide levels are elevated in patients with sepsis. Surgery 1990; 108: 1097.
  • Mimos O, Benoist JF, Edouard AR et al.: Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24: 185-88.
  • Brunkhorst FM, Forycki ZF, Beier W et al.: Discrimination of infectious and non-infectious etiologies of the adult respiratory distress syndrome (ARDS) with procalcitonin immunoreactivity. Clin Intensive Care 1993; 3 (suppl); 12.
  • Nylen ES, O'Neill WO, Jordan MH et al.: Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res 1992; 24: 439.[PubMed][Crossref]
  • Haupt W, Fritsche H, Hohenberger W et al.: Selective cytokine release induced by serum and separated plasma from septic patients. Eur J Surg 1996; 162: 769.
  • Reith HB, Dittrich H, Haarmann W et al.: Adjuvante Therapie der Peritonitis und ihrer septischer Verlaufsformen mit Taurolidin - eine prospektive randomisierte Untersuchung. Chir Gastroenterologie 1996; 12: 358.[Crossref]
  • Marshall JC: Clinical trials of mediator-directed therapy in sepsis: what have we learnd? Intensive Care Med 2000; 26: S75-83.
  • Opal SM, Cross AS, Bhattacharjee AK et al.: Immunoprophylaxis against bacterial sepsis. Sepsis 1999; 3: 225-34.
  • Zanetti G, Calandra T: Intravenous immunoglobulins and granulocyte colony-stimulating factor for the management of infection in intensive care units. Curr Opin Crit Care 1997; 3: 342-47.
  • NIH Consensus conference. Intravenous immunoglobulins. Prevention and treatment of disease. JAMA 1990; 264: 3189-93.
  • Alejandria MM, Lansang MA, Dans LF et al.: Intravenous immunoglobulines for treating sepsis and septic shock (Cochrane-review) The Cochrane Library 3: 1999 and update 2000.
  • Werdan K: Immunoglobulins in sepsis: therapeutic use of immunoglobulins. Sepsis 1999; 3: 239-45.
  • Chen JY: Intravenous immunoglobulin in the treatment of full term and premature newborns with sepsis. J Formos Med Assoc 1996; 24: 733-42.
  • Grundmann R, Hornung M: Immunoglobulin-therapy in patients with endotoxinemia and postoperative sepsis - a prospective randomized study. Progress in clinical and biological Research 1988; 339-49.
  • Garbett ND, Munro CS, Cole PJ: Opsonic activity of an new intravenous immunoglobulin preparation: pentaglobin compared with sandoglobulin. Clinical Experimental Immunol 1989; 76: 3-12.
  • Schedel I, Dreikhausen U, Nentwig B et al.: Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective randomized clinical trial. Clinical Care Med 1991; 10: 1104-13.
  • Concato J, Shah N, Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research design. NEJM 2000; 342 (25): 1887-92.

Document Type

Publication order reference


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.